Unknown

Dataset Information

0

Pharmacogenetic approach at the serotonin transporter gene as a method of reducing the severity of alcohol drinking.


ABSTRACT: Severe drinking can cause serious morbidity and death. Because the serotonin transporter (5-HTT) is an important regulator of neuronal 5-HT function, allelic differences at that gene may modulate the severity of alcohol consumption and predict therapeutic response to the 5-HT(3) receptor antagonist, ondansetron.The authors randomized 283 alcoholics by genotype in the 5'-regulatory region of the 5-HTT gene (LL/LS/SS), with additional genotyping for another functional single-nucleotide polymorphism (T/G), rs1042173, in the 3'-untranslated region, in a double-blind controlled trial. Participants received either ondansetron (4 ?g/kg twice daily) or placebo for 11 weeks, plus standardized cognitive-behavioral therapy.Individuals with the LL genotype who received ondansetron had a lower mean number of drinks per drinking day (-1.62) and a higher percentage of days abstinent (11.27%) than those who received placebo. Among ondansetron recipients, the number of drinks per drinking day was lower (-1.53) and the percentage of days abstinent higher (9.73%) in LL compared with LS/SS individuals. LL individuals in the ondansetron group also had a lower number of drinks per drinking day (-1.45) and a higher percentage of days abstinent (9.65%) than all other genotype and treatment groups combined. For both number of drinks per drinking day and percentage of days abstinent, 5'-HTTLPR and rs1042173 variants interacted significantly. LL/TT individuals in the ondansetron group had a lower number of drinks per drinking day (-2.63) and a higher percentage of days abstinent (16.99%) than all other genotype and treatment groups combined.The authors propose a new pharmacogenetic approach using ondansetron to treat severe drinking and improve abstinence in alcoholics.

SUBMITTER: Johnson BA 

PROVIDER: S-EPMC3063997 | biostudies-literature | 2011 Mar

REPOSITORIES: biostudies-literature

altmetric image

Publications

Pharmacogenetic approach at the serotonin transporter gene as a method of reducing the severity of alcohol drinking.

Johnson Bankole A BA   Ait-Daoud Nassima N   Seneviratne Chamindi C   Roache John D JD   Javors Martin A MA   Wang Xin-Qun XQ   Liu Lei L   Penberthy J Kim JK   DiClemente Carlo C CC   Li Ming D MD  

The American journal of psychiatry 20110119 3


<h4>Objective</h4>Severe drinking can cause serious morbidity and death. Because the serotonin transporter (5-HTT) is an important regulator of neuronal 5-HT function, allelic differences at that gene may modulate the severity of alcohol consumption and predict therapeutic response to the 5-HT(3) receptor antagonist, ondansetron.<h4>Method</h4>The authors randomized 283 alcoholics by genotype in the 5'-regulatory region of the 5-HTT gene (LL/LS/SS), with additional genotyping for another functio  ...[more]

Similar Datasets

| S-EPMC4544820 | biostudies-literature
| S-EPMC3280410 | biostudies-literature
| S-EPMC5191998 | biostudies-literature
| S-EPMC5340078 | biostudies-literature
| S-EPMC4080683 | biostudies-literature
| S-EPMC2802220 | biostudies-literature
| S-EPMC5000669 | biostudies-literature
| S-EPMC3564922 | biostudies-other
| S-EPMC2932830 | biostudies-literature
| S-EPMC2679964 | biostudies-literature